These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 10817323)
1. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323 [TBL] [Abstract][Full Text] [Related]
2. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651 [TBL] [Abstract][Full Text] [Related]
3. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032 [TBL] [Abstract][Full Text] [Related]
7. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593 [TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of iodine scintigraphy and computerized tomography in the localization of pheochromocytoma]. de Graaf JS; Klooster NJ; de Lange WE; Piers DA; Zwierstra RP Ned Tijdschr Geneeskd; 1991 Dec; 135(50):2383-7. PubMed ID: 1749444 [TBL] [Abstract][Full Text] [Related]
12. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma. Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579 [TBL] [Abstract][Full Text] [Related]
13. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016 [TBL] [Abstract][Full Text] [Related]
14. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B. Yamamoto Y; Isobe Y; Nishiyama Y; Takashima H; Ohkawa M; Kihara M; Matsusaka K; Miyauchi A; Kobayashi S; Tanabe M Clin Nucl Med; 1998 Jan; 23(1):13-5. PubMed ID: 9442958 [TBL] [Abstract][Full Text] [Related]
15. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma. Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017 [TBL] [Abstract][Full Text] [Related]
16. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine]. Pucar D; Marković S Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993 [TBL] [Abstract][Full Text] [Related]
17. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665 [TBL] [Abstract][Full Text] [Related]
18. [Results of 25-year pheochromocytoma treatment in the Groningen Academic Hospital]. de Graaf JS; Nieweg OE; Oosterkamp AE; Zwierstra RP Ned Tijdschr Geneeskd; 1997 Jan; 141(3):148-51. PubMed ID: 9053762 [TBL] [Abstract][Full Text] [Related]
19. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464 [TBL] [Abstract][Full Text] [Related]
20. Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary. Mihai R; Gleeson F; Roskell D; Parker A; Sadler G Langenbecks Arch Surg; 2008 Sep; 393(5):725-7. PubMed ID: 18663465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]